ECSP067004A - Formulación en aerosol para la inhalación de beta-agonistas - Google Patents

Formulación en aerosol para la inhalación de beta-agonistas

Info

Publication number
ECSP067004A
ECSP067004A EC2006007004A ECSP067004A ECSP067004A EC SP067004 A ECSP067004 A EC SP067004A EC 2006007004 A EC2006007004 A EC 2006007004A EC SP067004 A ECSP067004 A EC SP067004A EC SP067004 A ECSP067004 A EC SP067004A
Authority
EC
Ecuador
Prior art keywords
inhalation
aerosol formulation
agonists
beta
radicals
Prior art date
Application number
EC2006007004A
Other languages
English (en)
Inventor
Michael Aven
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP067004(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of ECSP067004A publication Critical patent/ECSP067004A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La presente invención se refiere a una formulación en aerosol sin gas propelente que contiene uno o varios compuestos de la fórmula general 1 1en la que los radicales R1, R2, R3 y X- pueden tener los significados mencionados en las reivindicaciones y en la descripción, para la inhalación.
EC2006007004A 2004-05-14 2006-11-13 Formulación en aerosol para la inhalación de beta-agonistas ECSP067004A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004024452A DE102004024452A1 (de) 2004-05-14 2004-05-14 Aerosolformulierung für die Inhalation von Betaagonisten

Publications (1)

Publication Number Publication Date
ECSP067004A true ECSP067004A (es) 2007-02-28

Family

ID=34979667

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006007004A ECSP067004A (es) 2004-05-14 2006-11-13 Formulación en aerosol para la inhalación de beta-agonistas

Country Status (26)

Country Link
EP (1) EP1809293B1 (es)
JP (1) JP4620730B2 (es)
KR (1) KR101288791B1 (es)
CN (1) CN101056640A (es)
AR (1) AR049096A1 (es)
AU (1) AU2005244414B2 (es)
BR (1) BRPI0511135B8 (es)
CA (1) CA2564379C (es)
DE (1) DE102004024452A1 (es)
DK (1) DK1809293T3 (es)
EA (1) EA012583B1 (es)
EC (1) ECSP067004A (es)
ES (1) ES2575925T3 (es)
HU (1) HUE027780T2 (es)
IL (1) IL179218A (es)
MX (1) MXPA06013216A (es)
MY (1) MY148403A (es)
NO (1) NO20065030L (es)
PE (1) PE20060311A1 (es)
PL (1) PL1809293T3 (es)
SG (1) SG152265A1 (es)
TW (1) TWI356703B (es)
UA (1) UA87312C2 (es)
UY (1) UY28891A1 (es)
WO (1) WO2005110421A2 (es)
ZA (1) ZA200607462B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2530991T3 (es) 2005-08-15 2015-03-09 Boehringer Ingelheim Int Procedimiento para la obtención de betamiméticos
US20080280897A1 (en) * 2005-11-09 2008-11-13 Michael Aven Aerosol Formulation for Inhalation
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
CA2738617A1 (en) * 2008-11-21 2011-05-27 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta agonists
EP2358353A1 (en) * 2008-11-21 2011-08-24 Boehringer Ingelheim International GmbH Aerosol formulation for the inhalation of beta agonists
EP2906218B1 (en) 2012-10-09 2016-12-14 Boehringer Ingelheim International GmbH Beta-2-adrenoceptor agonist for the treatment of cough
JP2019536812A (ja) 2016-12-12 2019-12-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング オロダテロールとの同時投与による間質性肺疾患の処置方法に使用するためのニンテダニブ
CN114746395A (zh) * 2019-12-05 2022-07-12 先正达农作物保护股份公司 用于制备苯基乙胺衍生物的一步方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004019539A1 (de) * 2004-04-22 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
ES2523518T3 (es) * 2004-04-22 2014-11-26 Boehringer Ingelheim International Gmbh Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias
DE102004024451A1 (de) * 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
TWI356703B (en) 2012-01-21
CN101056640A (zh) 2007-10-17
PE20060311A1 (es) 2006-05-08
HUE027780T2 (en) 2016-11-28
ES2575925T3 (es) 2016-07-04
BRPI0511135B1 (pt) 2019-11-12
BRPI0511135B8 (pt) 2021-05-25
ZA200607462B (en) 2008-06-25
JP2007537188A (ja) 2007-12-20
SG152265A1 (en) 2009-05-29
TW200608981A (en) 2006-03-16
CA2564379A1 (en) 2005-11-24
AU2005244414A1 (en) 2005-11-24
NO20065030L (no) 2006-11-30
AR049096A1 (es) 2006-06-28
DK1809293T3 (en) 2016-06-20
WO2005110421A2 (de) 2005-11-24
UY28891A1 (es) 2005-12-30
IL179218A0 (en) 2007-03-08
PL1809293T3 (pl) 2016-09-30
MY148403A (en) 2013-04-30
WO2005110421A3 (de) 2006-03-16
MXPA06013216A (es) 2007-02-08
BRPI0511135A (pt) 2007-11-27
KR101288791B1 (ko) 2013-07-29
EA200602017A1 (ru) 2007-06-29
DE102004024452A1 (de) 2005-12-08
KR20070022084A (ko) 2007-02-23
EA012583B1 (ru) 2009-10-30
AU2005244414B2 (en) 2010-12-09
CA2564379C (en) 2013-07-30
IL179218A (en) 2012-10-31
JP4620730B2 (ja) 2011-01-26
UA87312C2 (ru) 2009-07-10
EP1809293A2 (de) 2007-07-25
EP1809293B1 (de) 2016-03-16

Similar Documents

Publication Publication Date Title
ECSP088294A (es) Formulación en aerosol para la inhalación de beta-agonistas
UY30542A1 (es) Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) Formulacion de aerosol para la inhalacion de beta- agonistas
ECSP066541A (es) Nuevos derivados de piridazin-3(2h)-ona
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CO6160235A2 (es) Isoxazolinas insecticidas
DOP2009000257A (es) Inhibidores de cinasa p70 s6
CR8986A (es) Isoxazoles sustituidos como fungicidas
ECSP099335A (es) Compuestos heterocíclicos que contienen nitrógeno y métodos de uso de los mismos
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
AR062211A1 (es) Derivados de 6-carboxi-normorfinano. composiciones farmaceuticas
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ECSP067004A (es) Formulación en aerosol para la inhalación de beta-agonistas
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
EA200870018A1 (ru) Новый комплекс применения для стабилизации гербицидных композиций и способы его синтеза и использования
UY27980A1 (es) Indoles 2,7-sustituidos
SV2003000995A (es) Nuevas arilsulfonamidas como agentes antivirales ref. lea35214-sv
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
UY30555A1 (es) Formulacion aerosol para la inhalacion de beta-agonistas
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
UY28434A1 (es) Compuestos
UY29510A1 (es) Derivados de urea, metodos para su fabricación, y usos de los mismos
NO20081587L (no) Aerosolformulering for inhalering
UY30552A1 (es) Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones